FDA Approves Additional Doses of Trulicity (dulaglutide) for the Treatment of Type 2 Diabetes

Article Link: FDA Approves Additional Doses of Trulicity (dulaglutide) for the Treatment of Type 2 Diabetes

INDIANAPOLIS, Sept. 3, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) today approved two additional doses of Eli Lilly and Company’s (NYSE: LLY) Trulicity® (dulaglutide). The approval expands the…

Source: FDA New Drug Approvals